The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC).
Robert John Motzer
Consultant or Advisory Role - Pfizer
Research Funding - Astellas Pharma; AVEO; GlaxoSmithKline; Novartis; Pfizer
Carlos H. Barrios
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Tae Min Kim
No relevant relationships to disclose
Silvia Falcon
No relevant relationships to disclose
Thomas Cosgriff
Research Funding - Novartis
W. Graydon Harker
No relevant relationships to disclose
Kenneth B. Pittman
No relevant relationships to disclose
Roberto Sabbatini
Disclosure not yet available
Sun Young Rha
No relevant relationships to disclose
Thomas W. Flaig
Employment or Leadership Position - Aurora Oncology (Other)
Consultant or Advisory Role - GTx; Sanofi
Honoraria - Amgen
Research Funding - Amgen; Bayer/Onyx; BN ImmunoTherapeutics; Cougar Biotechnology; Dendreon; Genentech; GlaxoSmithKline; GTx; Janssen Oncology; Medivation; Novartis; Pfizer; Sanofi ; Veridex; Zymogenetics
Other Remuneration - Aurora Oncology (Intellectual Property Interests)
Ray D. Page
Research Funding - Novartis
Sevil E. Bavbek
Honoraria - Novartis
J. Thaddeus Beck
No relevant relationships to disclose
Poulam M Patel
No relevant relationships to disclose
Edward Schiff
Employment or Leadership Position - Novartis
Alexandra Vaury
Employment or Leadership Position - Novartis
Julie Niolat
Employment or Leadership Position - Novartis
Sven Gogov
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Ozlem Anak
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Jennifer Knox
Research Funding - Novartis; Pfizer